4.5 Article

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

No association of DNM3 with age of onset in Asian Parkinson's disease

J. N. Foo et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Article Cell Biology

LRRK2 activation in idiopathic Parkinson's disease

Roberto Di Maio et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Neurosciences

Tracking Parkinson's: Study Design and Baseline Patient Data

Naveed Malek et al.

JOURNAL OF PARKINSONS DISEASE (2015)

Article Neurosciences

Genetic variability in the regulation of gene expression in ten regions of the human brain

Adaikalavan Ramasamy et al.

NATURE NEUROSCIENCE (2014)

Editorial Material Clinical Neurology

LRRK2 PARKINSONISM IN TUNISIA AND NORWAY: A COMPARATIVE ANALYSIS OF DISEASE PENETRANCE

Faycel Hentati et al.

NEUROLOGY (2014)

Article Clinical Neurology

Common variation in theLRRK2gene is a risk factor for Parkinson's disease

Ignacio F. Mata et al.

MOVEMENT DISORDERS (2012)

Article Multidisciplinary Sciences

An anatomically comprehensive atlas of the adult human brain transcriptome

Michael J. Hawrylycz et al.

NATURE (2012)

Article Geriatrics & Gerontology

No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort

Ruben Fernandez-Santiago et al.

NEUROBIOLOGY OF AGING (2011)

Article Medicine, General & Internal

Whole-genome analysis of sporadic amyotrophic lateral sclerosis

Travis Dunckley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)